Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF vs. AraC + G-CSF for Stem Cell Mobilization in Lymphoma
NCT02722733Phase 3Unknown
- Sponsor
- Maria Skłodowska-Curie National Research Institute of Oncology
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cytarabine in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Maria Skłodowska-Curie National Research Institute of Oncology. Status: unknown.
02
Drugs
cytarabine
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02722733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722733.